Zobrazeno 1 - 10
of 199
pro vyhledávání: '"Brusamolino, A."'
Autor:
Mirko Marino, Daniela Martini, Salvatore Ciappellano, Antonella Brusamolino, Claudio Gardana, Alberto Battezzati, Patrizia Riso, Marisa Porrini, Cristian Del Bo
Publikováno v:
Nutrition Research. 105:126-137
Autor:
Andrea Toniato, Chiara Gamba, Jan Walter Schroeder, Valeria Fabbri, Scarlett Valeria Bernal Ortiz, Linda Borgonovo, Marta Piantanida, Joseph Scibilia, Luca Balossi, Eleonora Brusamolino, Emanuela Bonoldi, Valentina Caputo, Michele Nichelatti, Elide Anna Pastorello
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 13, p 7072 (2021)
DRESS/DiHS is a complex and potentially fatal drug reaction. Little is known about risk factors and elements that can help to identify patients with a severe reaction early. The aim of the study was to investigate those factors favoring the disease a
Externí odkaz:
https://doaj.org/article/6e325fe86d2c4a348aee02bd90f7e2fb
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 1 (2014)
Patients with Hodgkin lymphoma treated with DNA-breaking alkylating agents such as mechloretamine and procarbazine in the MOPP regimen and with topoisomerase II inhibitors, such as etoposide did show a long-term risk of developing therapy-related mye
Externí odkaz:
https://doaj.org/article/8f99a7a710e74173a3f538fbbabd6db3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Patrizia Riso, Alberto Battezzati, Claudio Gardana, Salvatore Ciappellano, Antonella Brusamolino, Cristian Del Bo
Publikováno v:
Clinical Nutrition. 38:575-583
Summary Background & aims Vegetarians and vegans are more vulnerable to vitamin B12 deficiency with severe risks of megaloblastic anemia, cognitive decline, neuropathy, and depression. An easy and simple method of supplementation consists of taking o
Autor:
Pier Luigi Zinzani, Simonetta Viviani, Antonella Anastasia, Umberto Vitolo, Stefano Luminari, Francesco Zaja, Paolo Corradini, Michele Spina, Ercole Brusamolino, Alessandro M. Gianni, Armando Santoro, Barbara Botto, Enrico Derenzini, Cinzia Pellegrini, Lisa Argnani
Publikováno v:
Haematologica, Vol 98, Iss 8 (2013)
Clinical trial results indicate that brentuximab vedotin brings considerable promise for the treatment of patients with relapsed or refractory Hodgkin’s lymphoma. A retrospective multicenter study was conducted on 65 heavily pretreated patients who
Externí odkaz:
https://doaj.org/article/62214aec77b64320ac661ee34dc9b24c
Autor:
Brusamolino, Ercole
Publikováno v:
In EJC Supplements 2008 6(2):31-36
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 4, Iss 1, Pp e2012022-e2012022 (2012)
Patients with Hodgkin lymphoma treated with DNA-breaking alkylating agents such as mechlorethamine and procarbazine in the MOPP regimen and with topoisomerase II inhibitors, such as etoposide did show a long-term risk of developing therapy-related my
Externí odkaz:
https://doaj.org/article/e0a0f3742e9046ada2025539204ffa1c
Autor:
Francesco Zaja, Stefano De Luca, Umberto Vitolo, Lorella Orsucci, Alessandro Levis, Flavia Salvi, Chiara Rusconi, Erika Ravelli, Alessandra Tucci, Chiara Bottelli, Monica Balzarotti, Ercole Brusamolino, Maurizio Bonfichi, Stefano A. Pileri, Elena Sabattini, Stefano Volpetti, Chiara Monagheddu, Angelo Vacca, Roberto Ria, Renato Fanin
Publikováno v:
Haematologica, Vol 97, Iss 3 (2012)
Background Preclinical studies have highlighted the activity of lenalidomide in mantle cell lymphoma and its anti-proliferative synergy with dexamethasone.Design and Methods In this prospective, multicenter, phase II study, patients with relapsed/ref
Externí odkaz:
https://doaj.org/article/833ce7ee81f64cb5baddd32b512672e7